Early breast cancer precursor lesions: Lessons learned from molecular and clinical studies

Breast Care

Volumn 5, Issue 4, 2010, Pages 218-226

  Sinn, Hans Peter ^a   Elsawaf, Zeinab ^a   Helmchen, Birgit ^b   Aulmann, Sebastian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Atypical ductal hyperplasia (ADH); Breast cancer, precursor; Flat epithelial atypia (FEA); Lobular neoplasia (LN)

Indexed keywords

ATYPICAL DUCTAL HYPERPLASIA; BREAST CANCER; BREAST LESION; CANCER DIAGNOSIS; CANCER RISK; CLINICAL STUDY; EARLY CANCER; FLAT EPITHELIAL ATYPIA; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LOBULAR NEOPLASIA; MOLECULAR BIOLOGY; NEEDLE BIOPSY; PRECANCER; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 77957092752     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000319624     Document Type: Review

References (107)

1. Johnson NB, Collins LC: Update on percutaneous needle biopsy of nonmalignant breast lesions. Adv Anat Pathol 2009;16:183-195.
2. Page DL, Jensen RA, Simpson JF, Dupont WD: Historical and epidemiologic background of human premalignant breast disease. J Mammary Gland Biol Neoplasia 2000;5:341-349.
3. Schnitt SJ: Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol 2003;27:836-841.
4. Weigelt B, Reis-Filho JS: Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 2009;6:718-730.
5. Allred DC, Mohsin SK, Fuqua SA: Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 2001;8:47-61.
6. Reis-Filho JS, Simpson PT, Gale T, Lakhani SR: The molecular genetics of breast cancer: the contribution of comparative genomic hybridization. Pathol Res Pract 2005;201:713-725.
7. Bürger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, Böcker W: Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 1999;187:396-402.
8. Abdel-Fatah T, Powe D, Hodi Z, Reis-Filho J, Lee A, Ellis I: Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol 2008;32:513-523.
9. Aulmann S, Elsawaf Z, Penzel R, Schirmacher P, Sinn HP: Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ. Am J Surg Pathol 2009;33:1646-1653.
10. Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis- Filho JS, Ellis IO: High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 2007;31:417-426.
11. Allred DC, Brown P, Medina D: The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res 2004;6:240-245.
12. Yan L, Yang X, Davidson NE: Role of DNA methylation and histone acetylation in steroid receptor expression in breast cancer. J Mammary Gland Biol Neoplasia 2001;6:183-192.
13. Borg A, Linell F, Idvall I, Johansson S, Sigurdsson H, Ferno M, Killander D: Her2/neu amplification and comedo type breast carcinoma. Lancet 1989;1:1268-1269.
14. Done S, Eskandarian S, Bull S, Redston M, Andrulis I: P53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast. J Natl Cancer Inst 2001;93:700-704.
15. Leibl S, Regitnig P, Moinfar F: Flat epithelial atypia (din 1a, atypical columnar change): an underdiagnosed entity very frequently coexisting with lobular neoplasia. Histopathology 2007;50:859-865.
16. Arpino G, Laucirica R, Elledge R: Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 2005;143:446-457.
17. Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD: Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer 2006;106:1453-1461.
18. Page DL, Salhany KE, Jensen RA, Dupont WD: Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer 1996;78:258-266.
19. Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ: Pathologic features of breast cancers in women with previous benign breast disease. Am J Clin Pathol 2001;115:362-369.
20. Böcker W: Preneoplasia of the Breast. A New Conceptual Approach to Proliferative Breast Disease. Munich, Saunders, Elsevier, 2006.
21. Page D, Rogers L: Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol 1992;23:1095-1097.
22. Tavassoli FA, Devilee P: Tumours of the Breast and Female Genital Organs. Pathology and Genetics. Lyon, IARC Press, 2003.
23. Nofech-Mozes S, Holloway C, Hanna W: The role of cytokeratin 5/6 as an adjunct diagnostic tool in breast core needle biopsies. Int J Surg Pathol 2008;16:399-406.
24. Bratthauer GL, Tavassoli FA: Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast. Virchows Arch 2004;444:340-344.
25. Perry N, Broeders M, Wolf CD: European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. Luxembourg, European Commission, 2006.
26. Gong G, DeVries S, Chew KL, Cha I, Ljung BM, Waldman FM: Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res 2001;7:2410-2414.
27. Amari M, Suzuki A, Moriya T, Yoshinaga K, Amano G, Sasano H, Ohuchi N, Satomi S, Horii A: Loh analyses of premalignant and malignant lesions of human breast: frequent loh in 8p, 16q, and 17q in atypical ductal hyperplasia. Oncol Rep 1999;6:1277-1280.
28. Lakhani SR, Collins N, Stratton MR, Sloane JP: Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 1995;48:611-615.
29. Reis-Filho J, Lakhani S: The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 2003;5:313-319.
30. Yeh IT, Dimitrov D, Otto P, Miller AR, Kahlenberg MS, Cruz A: Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med 2003;127:49-54.
31. Kohr JR, Eby PR, Allison KH, Demartini WB, Gutierrez RL, Peacock S, Lehman CD: Risk of upgrade of atypical ductal hyperplasia after stereotactic breast biopsy: effects of number of foci and complete removal of calcifications. Radiology 2010;255:723-730.
32. Azzopardi JG, Ahmed A, Millis RR: Problems in Breast Pathology. Philadelphia, PA, Saunders, 1979.
33. Schnitt S, Vincent-Salomon A: Columnar cell lesions of the breast. Adv Anat Pathol 2003;10:113-124.
34. OMalley F, Mohsin S, Badve S, Bose S, Collins L, Ennis M, Kleer C, Pinder S, Schnitt S: Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol 2006;19:172-179.
35. Fraser J, Raza S, Chorny K, Connolly J, Schnitt S: Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol 1998;22:1521-1527.
36. Chivukula M, Bhargava R, Tseng G, Dabbs DJ: Clinicopathologic implications of Flat epithelial atypia in core needle biopsy specimens of the breast. Am J Clin Pathol 2009;131:802-808.
37. Rosen P: Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol 1999;23:1561.
38. Brandt SM, Young GQ, Hoda SA: The Rosen triad: tubular carcinoma, lobular carcinoma in situ, and columnar cell lesions. Adv Anat Pathol 2008;15:140-146.
39. Moinfar F, Man Y, Bratthauer G, Ratschek M, Tavassoli F: Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (clinging ductal carcinoma in situ): a simulator of normal mammary epithelium. Cancer 2000;88:2072-2081.
40. Kunju LP, Kleer CG: Significance of flat epithelial atypia on mammotome core needle biopsy: should it be excised? Hum Pathol 2007;38:35-41.
41. Martel M, Barron-Rodriguez P, Tolgay Ocal I, Dotto J, Tavassoli FA: Flat din 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992-1999). Virchows Arch 2007;451:883-891.
42. Pinder SE, Reis-Filho JS: Non-operative breast pathology: columnar cell lesions. J Clin Pathol 2007;60:1307-1312.
43. Contreras A, Sattar H: Lobular neoplasia of the breast: an update. Arch Pathol Lab Med 2009;133:1116-1120.
44. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF: Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003;361:125-129.
45. Hwang E, Nyante S, Yi Chen Y, Moore D, DeVries S, Korkola J, Esserman L, Waldman F: Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004;100:2562-2572.
46. Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ: E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997;76:1131-1133.
47. Aulmann S, Penzel R, Longerich T, Funke B, Schirmacher P, Sinn HP: Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer. Breast Cancer Res Treat 2008;107:331-335.
48. Bodian CA, Perzin KH, Lattes R: Lobular neoplasia. Long term risk of breast cancer and relation to other factors. Cancer 1996;78:1024-1034.
49. Chivukula M, Haynik DM, Brufsky A, Carter G, Dabbs DJ: Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol 2008;32:1721-1726.
50. Bratthauer GL, Tavassoli FA: Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002;440:134-138.
51. Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA: Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish breast cancer cooperative group. Am J Surg Pathol 1993;17:14-21.
52. Rosen PP: Rosens Breast Pathology, 2nd ed. Philadelphia, PA, Lippincott Williams and Wilkins, 2001.
53. Stein LF, Zisman G, Rapelyea JA, Schwartz AM, Abell B, Brem RF: Lobular carcinoma in situ of the breast presenting as a mass. AJR Am J Roentgenol 2005;184:1799-1801.
54. Shin SJ, Rosen PP: Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med 2002;126:697-701.
55. Elsheikh TM, Silverman JF: Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 2005;29:534-543.
56. Nagi CS, ODonnell JE, Tismenetsky M, Bleiweiss IJ, Jaffer SM: Lobular neoplasia on core needle biopsy does not require excision. Cancer 2008;112:2152-2158.
57. Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA Jr: Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994;193:91-95.
58. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP: Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol 1995;164:1111-1113.
59. Tocino I, Garcia BM, Carter D: Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsy. Ann Surg Oncol 1996;3:483-488.
60. Nguyen M, McCombs MM, Ghandehari S, Kim A, Wang H, Barsky SH, Love S, Bassett LW: An update on core needle biopsy for radiologically detected breast lesions. Cancer 1996;78:2340-2345.
61. Burbank F: Stereotactic breast biopsy: comparison of 14- and 11-gauge mammotome probe performance and complication rates. Am Surg 1997;63:988-995.
62. Lee CH, Egglin TK, Philpotts L, Mainiero MB, Tocino I: Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. Radiology 1997;202:849-854.
63. Liberman L, Dershaw DD, Glassman JR, Abramson AF, Morris EA, LaTrenta LR, Rosen PP: Analysis of cancers not diagnosed at stereotactic core breast biopsy. Radiology 1997;203:151-157.
64. Moore MM, Hargett CW 3rd, Hanks JB, Fajardo LL, Harvey JA, Frierson HF Jr, Slingluff CL Jr: Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy. Ann Surg 1997;225:726-731; discussion 731-1723
65. Gadzala DE, Cederbom GJ, Bolton JS, McKinnon WM, Farr GH Jr, Champaign J, Ordoyne K, Chung K, Fuhrman GM: Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy. Ann Surg Oncol 1997;4:283-286.
66. Meyer JE, Smith DN, Lester SC, DiPiro PJ, Denison CM, Harvey SC, Christian RL, Richardson A, Ko WD: Large-needle core biopsy: nonmalignant breast abnormalities evaluated with surgical excision or repeat core biopsy. Radiology 1998;206:717-720.
67. Lin PH, Clyde JC, Bates DM, Garcia JM, Matsumoto GH, Girvin GW: Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia. Am J Surg 1998;175:380-382.
68. Fuhrman GM, Cederbom GJ, Bolton JS, King TA, Duncan JL, Champaign JL, Smetherman DH, Farr GH, Kuske RR, McKinnon WM: Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities. Ann Surg 1998;227:932-939.
69. Brem RF, Behrndt VS, Sanow L, Gatewood OM: Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR Am J Roentgenol 1999;172:1405-1407.
70. Burak WE Jr, Owens KE, Tighe MB, Kemp L, Dinges SA, Hitchcock CL, Olsen J: Vacuumassisted stereotactic breast biopsy: histologic underestimation of malignant lesions. Arch Surg 2000;135:700-703.
71. Philpotts LE, Lee CH, Horvath LJ, Lange RC, Carter D, Tocino I: Underestimation of breast cancer with II-gauge vacuum suction biopsy. AJR Am J Roentgenol 2000;175:1047-1050.
72. OHea B J, Tornos C: Mild ductal atypia after large-core needle biopsy of the breast: is surgical excision always necessary? Surgery 2000;128:738-743.
73. Adrales G, Turk P, Wallace T, Bird R, Norton HJ, Greene F: Is surgical excision necessary for atypical ductal hyperplasia of the breast diagnosed by mammotome? Am J Surg 2000;180:313-315.
74. Darling ML, Smith DN, Lester SC, Kaelin C, Selland DL, Denison CM, DiPiro PJ, Rose DI, Rhei E, Meyer JE: Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol 2000;175:1341-1346.
75. Cangiarella J, Waisman J, Symmans WF, Gross J, Cohen JM, Wu H, Axelrod D: Mammotome core biopsy for mammary microcalcification: analysis of 160 biopsies from 142 women with surgical and radiologic followup. Cancer 2001;91:173-177.
76. Lai JT, Burrowes P, MacGregor JH: Diagnostic accuracy of a stereotaxically guided vacuum-assisted large-core breast biopsy program in canada. Can Assoc Radiol J 2001;52:223-227.
77. Jackman RJ, Birdwell RL, Ikeda DM: Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum- assisted biopsy, eliminating the recommendation for surgical excision? Radiology 2002;224:548-554.
78. Liberman L, Kaplan JB, Morris EA, Abramson AF, Menell JH, Dershaw DD: To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy? AJR Am J Roentgenol 2002;179:679-683.
79. Zhao L, Freimanis R, Bergman S, Shen P, Perrier ND, Lesko N, Pulaski T, Pulaski S, Carr JJ, Levine EA: Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities. Am Surg 2003;69:757- 762; discussion 762.
80. Lourenco AP, Mainiero MB, Lazarus E, Giri D, Schepps B: Stereotactic breast biopsy: comparison of histologic underestimation rates with 11- and 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol 2007;189:W275-279.
81. Doren E, Hulvat M, Norton J, Rajan P, Sarker S, Aranha G, Yao K: Predicting cancer on excision of atypical ductal hyperplasia. Am J Surg 2008;195:358-361; discussion 361-1352
82. Wagoner MJ, Laronga C, Acs G: Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol 2009;131:112-121.
83. Arora S, Moezzi M, Kim U, Menes TS: Is surgical excision necessary for atypical ductal hyperplasia diagnosed with 8 gauge stereotactic biopsy? Breast J 2009;15:673-674.
84. Chae BJ, Lee A, Song BJ, Jung SS: Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy. World J Surg Oncol 2009;7:77.
85. Eby PR, Ochsner JE, DeMartini WB, Allison KH, Peacock S, Lehman CD: Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9- versus 11-gauge. AJR Am J Roentgenol 2009;192:229-234.
86. Youk JH, Kim EK, Kim MJ: Atypical ductal hyperplasia diagnosed at sonographically guided 14-gauge core needle biopsy of breast mass. AJR Am J Roentgenol 2009;192:1135-1141.
87. Guerra-Wallace MM, Christensen WN, White RL Jr: A retrospective study of columnar alteration with prominent apical snouts and secretions and the association with cancer. Am J Surg 2004;188:395-398.
88. Piubello Q, Parisi A, Eccher A, Barbazeni G, Franchini Z, Iannucci A: Flat epithelial atypia on core needle biopsy: which is the right management? Am J Surg Pathol 2009;33:1078-1084.
89. Hayes BD, ODoherty A, Quinn CM: Correlation of needle core biopsy with excision histology in screen-detected b3 lesions: the Merrion Breast Screening Unit experience. J Clin Pathol 2009;62:1136-1140.
90. Noel JC, Fayt I, Fernandez-Aguilar S, Buxant F, Boutemy R: Proliferating activity in columnar cell lesions of the breast. Virchows Arch 2006;449:617-621.
91. Noske A, Pahl S, Fallenberg E, Richter-Ehrenstein C, Buckendahl AC, Weichert W, Schneider A, Dietel M, Denkert C: Flat epithelial atypia is a common subtype of b3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology. Hum Pathol 2010;41:522-527.
92. Ingegnoli A, dAloia C, Frattaruolo A, Pallavera L, Martella E, Crisi G, Zompatori M: Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate. Breast J 2010;16:55-59.
93. Liberman L, Sama M, Susnik B, Rosen PP, LaTrenta LR, Morris EA, Abramson AF, Dershaw DD: Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR Am J Roentgenol 1999;173:291-299.
94. Berg WA, Mrose HE, Ioffe OB: Atypical lobular hyperplasia or lobular carcinoma in situ at coreneedle breast biopsy. Radiology 2001;218:503-509.
95. ODriscoll D, Britton P, Bobrow L, Wishart GC, Sinnatamby R, Warren R: Lobular carcinoma in situ on core biopsy - what is the clinical significance? Clin Radiol 2001;56:216-220.
96. Renshaw AA, Cartagena N, Derhagopian RP, Gould EW: Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 2002;117:797-799.
97. Irfan K, Brem RF: Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuumassisted biopsy. Breast J 2002;8:230-233.
98. Bauer VP, Ditkoff BA, Schnabel F, Brenin D, El- Tamer M, Smith S: The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J 2003;9:4-9.
99. Bonnett M, Wallis T, Rossmann M, Pernick NL, Bouwman D, Carolin KA, Visscher D: Histopathologic analysis of atypical lesions in image-guided core breast biopsies. Mod Pathol 2003;16:154-160.
100. Crisi GM, Mandavilli S, Cronin E, Ricci A Jr: Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol 2003;27:325-333.
101. Dmytrasz K, Tartter PI, Mizrachy H, Chinitz L, Rosenbaum Smith S, Estabrook A: The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J 2003;9:10-12.
102. Middleton LP, Grant S, Stephens T, Stelling CB, Sneige N, Sahin AA: Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol 2003;16:120-129.
103. Arpino G, Allred DC, Mohsin SK, Weiss HL, Conrow D, Elledge RM: Lobular neoplasia on core-needle biopsy - clinical significance. Cancer 2004;101:242-250.
104. Karabakhtsian RG, Johnson R, Sumkin J, Dabbs DJ: The clinical significance of lobular neoplasia on breast core biopsy. Am J Surg Pathol 2007;31:717-723.
105. Hwang H, Barke LD, Mendelson EB, Susnik B: Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary. Mod Pathol 2008;21:1208-1216.
106. Menon S, Porter GJ, Evans AJ, Ellis IO, Elston CW, Hodi Z, Lee AH: The significance of lobular neoplasia on needle core biopsy of the breast. Virchows Arch 2008;452:473-479.
107. Gao F, Carter G, Tseng G, Chivukula M: Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies. Am J Clin Pathol 2010;133:767-771.